The naturally occurring polymorphism Asp116→His116, differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition

European Journal of Immunology

Volumn 28, Issue 8, 1998, Pages 2508-2516

  Fiorillo, Maria Teresa ^a   Greco, Giulia ^b   Maragno, Monica ^a   Potolicchio, Ilaria ^a,b   Monizio, Andrea ^a   Dupuis, Maria Luisa ^c   Sorrentino, Rosa ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Ankylosing spondylitis; Cytotoxic T lymphocyte; HLA B27; Peptide analogue

Indexed keywords

ALANINE; ASPARTIC ACID; CD8 ANTIGEN; HISTIDINE; HLA B ANTIGEN;

AMINO ACID SUBSTITUTION; ANKYLOSING SPONDYLITIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HLA TYPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPONDYLOARTHROPATHY; T LYMPHOCYTE;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HLA-B27 ANTIGEN; HUMANS; OLIGOPEPTIDES; POLYMORPHISM, GENETIC; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VIRAL MATRIX PROTEINS;

EID: 0031903713     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199808)28:08<2508::AID-IMMU2508>3.0.CO;2-1     Document Type: Article

References (37)

1. Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. O. and Sturrock, R. D., Ankylosing spondylitis and HL-A 27. Lancet 1973. i: 904-907.
2. Schlosstein, L., Terasaki, P. I., Bluestone, R. and Pearson, C. M., High association of an HL-A antigen, W27, with ankylosing spondylitis. N. Engl. J. Med. 1973. 288: 704-706.
3. Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J. P. and Taurog, J. D., Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2-m: an animal model of HLA-B27-associated human disorders. Cell 1990. 63: 1099-1112.
4. MacLean, L., HLA-B27 subtypes: implications for the spondyloarthropathies. Ann. Rheum. Dis. 1992. 51: 929-931.
5. Benjamin, R. and Parham, P., Guilty by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 1990. 11: 137-142.
6. Hermann, E., Yu, D. T. Y., Meyer zum Büschenfelde, K. H. and Fleischer, B., HLA-B27-restricted T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993. 342: 646-650.
7. Lopez de Castro, J. A., The pathogenetic role of HLA-B27 in chronic arthritis. Curr. Opin. Immunol. 1998, 10: 59-66.
8. Breur-Vriesendorp, B. S., Dekker-Saeys, A. J. and Ivanyi, P., Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of various B27 molecules. Ann. Rheum. Dis. 1987. 46: 353-356.
9. D'Amato, M., Fiorillo, M. T., Galeazzi, M., Martinetti, M., Amoroso, A. and Sorrentino, R., Frequency of the new HLA-B*2709 allele in ankylosing spondylitis patients and healthy individuals. Dis. Markers 1995. 12: 215-217.
10. D'Amato, M., Fiorillo, M. T., Carcassi, C., Mathieu, A., Zuccarelli, A., Bitti, P. P., Tosi, R. and Sorrentino, R., Relevance of residue 116 of HLA-B27 in determining susceptibility to Ankylosing Spondylitis. Bur. J. Immunol. 1995. 25: 3199-3201.
11. Gonzales-Roces, S., Alvarez, M. V., Gonzales, S., Dieye, A., Makni, H., Woodfield, D. G., Housan, L., Konekov, V., Abbadi, M. C., Grunnet, N., Goto, E. and Lopez-Larrea, C., HLA-B27 polymorphism and world-wide susceptibility to ankylosing spondylitis. Tissue Antigens 1997. 49: 116-123.
12. Fiorillo, M. T., Meadows, L., D'Amato, M., Shabanowitz, J., Hunt, D. F., Appella, E. and Sorrentino, R., Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 1997. 27: 368-373.
13. Garcia, F., Marina, A. and Lopez de Castro, J. A., Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis. Tissue Antigens 1997. 49: 215-221.
14. Del Porto, P., D'Amato, M., Fiorillo, M. T., Tuosto, L., Piccolella, E. and Sorrentino, R., Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic γδ T cell clone. J. Immunol. 1994. 153: 3093-3100.
15. Fiorillo, M. T., Greco, G. and Sorrentino, R., The Asp 116-His 116 substitution in a novel HLA-B27 subtype influences the acceptance of the peptide C-terminal anchor, Immunogenetics 1995. 41: 38-39.
16. Rötzschke, O., Falk, K., Stevanović, S., Gnau, V., Jung, G. and Rammensee, H. G., Dominant aromatic/ aliphatic C-terminal anchor in HLA-B*2702 and -B*2705 peptide motifs, Immunogenetics 1994. 39: 74-77.
17. Jardetsky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R. and Wiley, D. C., Identification of self-peptides bound to purified HLA-B27. Nature 1991. 353: 326-329.
18. Miller, G., Epstein-Barr virus biology, pathogenesis and medical aspects. In Fields, B. N., Knipe, D. M., Channock, R., Hirsch, M., Melnick, T., Monath, T. and Roizman, B. (Eds.) Virology, 2nd Edn. Raven Press, New York 1990, pp 1921-1958.
19. Wallace, L. E., Rowe, M., Gaston, J. S. H., Rickinson, A. B. and Epstein, M. A., Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Bur. J. Immunol. 1982. 12: 1012-1018.
20. Rickinson, A. B. and Moss, D. J., Human cytotoxic T lymphocytes responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 1997. 15: 405-431.
21. Brooks, J. M., Murray, R. J., Thomas, W. A., Kurilla, M. G. and Rickinson, A. B., Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 1993. 178: 879-887.
22. Hill, A. B., Lee, S. P., Haurum, J. S., Murray, N., Yao, Q. Y., Rowe, M., Signoret, N., Rickinson, A. B. and McMichael, J., Class-I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid lines against which they were rised. J. Exp. Med. 1995. 181: 2221-2228.
23. + T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J. Immunol. 1997. 159: 1844-1852.
24. Madden, D. R., Gorga, J. C., Strominger, J. L. and Wiley, D. C., The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991. 353: 321-325.
25. Alam, S. M., Travers, P. J., Wung, J. L., Nashold, W., Redpath, S., Jameson, S. C. and Gascoigne, N. R. J., T-cell-receptor affinity and thymocyte positive selection. Nature 1996. 381: 616-620.
26. Hu, Q., Walker Bazemore, C. R., Girao, C., Opferman, J. T., Sun, J., Shabanowitz, J., Hunt, D. F. and Ashton-Rickard, P. G., Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. Immunity 1997. 7: 221-231.
27. Pazmany, L., Rowland-Jones, S., Huet, S., Hill, A., Sutton, J., Murray, R., Brooks, J. and McMichael, A., Genetic modulation of antigen presentation by HLA-B27 molecules. J. Exp. Med. 1992. 175: 361-369.
28. Calvo, V., Rojo, S., Lopez, D., Galocha, B. and Lopez de Castro, J. A., Structure and diversity of HLA-B27 specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J. Immunol. 1990. 144: 4038-4045.
29. Rammensee, H. G., Friede, T. and Stefanović, S., MHC ligands and peptide motifs: first listing. Immunogenetics 1995. 41: 178-228.
30. Klenerman, P., Rowland-Jones, S., Mc Adam, S., Edwards, J., Daenke, S., Lalloo, D., Koppe, B., Rosenberg, W., Boyd, D., Edwards, A., Giangrande, P., Phillips, R. and McMichael, A., Cytotoxic T cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 1994. 369: 403-407.
31. Hollsberg, P., Weber, W. E., Dangond, F., Batra, V., Sette, A. and Hafler, D. A., Differential activation of proliferation and cytotoxicity in human T cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 1995. 92: 4036-4040.
32. Dressel, A., Chin, J. L., Sette, A., Gausling, R., Hollsberg, P. and Hafler, D. A., Autoantigen recognition by human CD8 T cell clones. J. Immunol. 1997. 159: 4943-4951.
33. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C., Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996. 384: 134-141.
34. Bowness, P., Allen, R. L. and McMichael, A. J., Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27. Eur. J. Immunol. 1994. 24: 2357-2363.
35. Schmidt, D., Verdaguer, J., Averill, N. and Santamaria, P., A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 1997. 186: 1059-1075.
36. Kersh, G. and Allen, P. M., Essential flexibility in the T-cell recognition of antigen. Nature 1996. 380: 495-498.
37. Racioppi, L., Ronchese, F., Matis, L. A. and Germain, R. N., Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 1993. 177: 1047-1060.